Drugs / ONO-7746
last change Feb 2014 re-read 3 minutes ago

ONO-7746

Developed for
thrombocytopenia
Investigated by
Ono Pharmaceutical Co., Ltd. · Ono Pharma USA Inc

Trials 3

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01345214 May 2011 → Feb 2014 thrombocytopenia Ono Pharma USA Inc Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT01106664 Apr → Nov 2010 — Ono Pharmaceutical Co., Ltd. Completed No outcome recorded
Phase 1 NCT00956371 Aug 2009 → Mar 2010 — Ono Pharmaceutical Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as ONO-7746 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00956371 ↗
2

NCT01345214 ↗

NCT01106664 ↗